News

CMN Weekly (29 November 2024) - Your Weekly CRISPR Medicine News

Some of the best links we picked up around the internet

By: Gorm Palmgren - Nov. 29, 2024
News

Top picks

Research

Industry

Detection

Perspectives

Reviews

News from CRISPR Medicine News

To get more CRISPR Medicine News delivered to your inbox, sign up to the free weekly CMN Newsletter here.

Tags

HashtagArticleHashtagMissing linksHashtagNewsHashtagCMN WeeklyHashtagCRISPR Therapeutics AGHashtagIntellia Therapeutics, Inc.HashtagPoseida TherapeuticsHashtagRocheHashtagScribe Therapeutics

News: CMN Weekly (29 November 2024) - Your Weekly CRISPR Medicine News
CLINICAL TRIALS
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Chronic Hepatitis B, HBV, (NCT06680232)
Sponsors:
Precision BioSciences, Inc.
Indicator
IND Enabling
Phase I
Phase II
Phase III
Indicator
IND Enabling
Phase I
Phase II
Phase III
View all clinical trials
close
Search CRISPR Medicine